SynBioBeta 2027

SynBioBeta is the leading commercial conference for synthetic biology and engineered biology, held annually in San Jose and framed for 2027 around the convergence of AI and biology. The programme covers AI-designed proteins and protein dynamics, virtual biology and multiscale modelling, biomanufacturing scale-up and fermentation economics, programmable RNA and gene editing, sustainable food and materials, and AI-ready biological data infrastructure. The room mixes large pharma (GSK, Sanofi, Novo Nordisk, AstraZeneca), compute and AI companies (NVIDIA, OpenAI, Google), consumer brands (P&G, Mars, Unilever), 20+ venture funds, government agencies including DARPA and ARPA-H, and hundreds of startups. For bio founders it is the primary place where partnering, corporate venture and scale-up manufacturing conversations happen in one week.